EUVIMEDОткрийте EUVIMED
ÜbersichtsarbeitOpen access

Spatial Omics in Gastrointestinal Oncology: Recent Advances, Therapeutic Insights, and Clinical Translation

Lin Zhong, Qian Li, Ting Xiong, Shengzheng Lin, Kaining Wang, Guanying Li, Ye Yan, Jianhao Liu, Chuansong Xue

Journal of Cancer · 2026-01-30 · 17 (3) · 515-523

DOI: 10.7150/jca.127381 ↗

At a glance

Übersichtsarbeit in Journal of Cancer, published on 2026-01-30. Written by Lin Zhong and 8 co-authors. Institution: Internal Medicine of Three, Sanya City Traditional Chinese Medicine Hospital, Sanya, China. Cited 7 times so far (Crossref). The full text is freely available in PubMed Central.

РезюмеSubjectsБиблиографски данниCiteRelated studies

Abstract (original language)

Gastrointestinal (GI) cancers remain a leading cause of cancer-related morbidity and mortality worldwide, largely due to their molecular heterogeneity, complex tumor microenvironment (TME), and variable treatment responses. In recent years, the emergence of spatially resolved omics technologies-encompassing spatial transcriptomics, proteomics, metabolomics, and epigenomics-has revolutionized the ability to interrogate tumor architecture with unprecedented resolution. These methods enable precise mapping of cellular and molecular interactions within intact tissue contexts, thereby uncovering spatially defined niches that influence tumor progression, immune evasion, and therapeutic resistance. In GI malignancies such as colorectal, gastric, and esophageal cancers, spatial omics have provided critical insights into cancer-stromal-immune crosstalk, identified predictive biomarkers for immunotherapy and targeted agents, and guided the development of novel therapeutic strategies. This review synthesizes the latest advances in spatial omics applied to GI oncology over the past five years, with an emphasis on their integration into early diagnosis, treatment stratification, and real-time monitoring of therapeutic efficacy. We also discuss current challenges, including standardization, data integration, and clinical validation, as well as future directions for incorporating spatial profiling into routine oncology practice. By bridging the gap between bench discoveries and bedside applications, spatial omics hold transformative potential for achieving truly personalized treatment in gastrointestinal cancers.

Subjects

Author keywords

gastrointestinal cancerimmunotherapyprecision oncologyspatial omicstumor microenvironment

Authors and institutions

  • Internal Medicine of Three, Sanya City Traditional Chinese Medicine Hospital, Sanya, China.
  • Department of Oncology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, National Health Committee Key Laboratory of Pediatric Hematology & Oncology, Shanghai, China.

Cite

APA

Zhong, L., Li, Q., Xiong, T., Lin, S., Wang, K., Li, G., Yan, Y., Liu, J., & Xue, C. (2026). Spatial Omics in Gastrointestinal Oncology: Recent Advances, Therapeutic Insights, and Clinical Translation. Journal of Cancer, 17(3), 515-523. https://doi.org/10.7150/jca.127381

Vancouver

Zhong L, Li Q, Xiong T, Lin S, Wang K, Li G, et al. Spatial Omics in Gastrointestinal Oncology: Recent Advances, Therapeutic Insights, and Clinical Translation. Journal of Cancer. 2026;17(3):515-523. doi:10.7150/jca.127381

BibTeX
@article{Zhong2026,
  author = {Zhong, Lin and Li, Qian and Xiong, Ting and Lin, Shengzheng and Wang, Kaining and Li, Guanying and Yan, Ye and Liu, Jianhao and Xue, Chuansong},
  title = {Spatial Omics in Gastrointestinal Oncology: Recent Advances, Therapeutic Insights, and Clinical Translation},
  journal = {Journal of Cancer},
  year = {2026},
  volume = {17},
  number = {3},
  pages = {515--523},
  doi = {10.7150/jca.127381}
}
Start for free →